1. Home
  2. EDSA vs JTAI Comparison

EDSA vs JTAI Comparison

Compare EDSA & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • JTAI
  • Stock Information
  • Founded
  • EDSA 2015
  • JTAI 2018
  • Country
  • EDSA Canada
  • JTAI United States
  • Employees
  • EDSA N/A
  • JTAI N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • JTAI Blank Checks
  • Sector
  • EDSA Health Care
  • JTAI Finance
  • Exchange
  • EDSA Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • EDSA 6.2M
  • JTAI 7.1M
  • IPO Year
  • EDSA N/A
  • JTAI N/A
  • Fundamental
  • Price
  • EDSA $1.70
  • JTAI $3.86
  • Analyst Decision
  • EDSA Strong Buy
  • JTAI
  • Analyst Count
  • EDSA 1
  • JTAI 0
  • Target Price
  • EDSA $21.00
  • JTAI N/A
  • AVG Volume (30 Days)
  • EDSA 17.7K
  • JTAI 2.0M
  • Earning Date
  • EDSA 02-07-2025
  • JTAI 11-14-2024
  • Dividend Yield
  • EDSA N/A
  • JTAI N/A
  • EPS Growth
  • EDSA N/A
  • JTAI N/A
  • EPS
  • EDSA N/A
  • JTAI N/A
  • Revenue
  • EDSA N/A
  • JTAI $15,028,926.00
  • Revenue This Year
  • EDSA N/A
  • JTAI $21.49
  • Revenue Next Year
  • EDSA N/A
  • JTAI $10.05
  • P/E Ratio
  • EDSA N/A
  • JTAI N/A
  • Revenue Growth
  • EDSA N/A
  • JTAI 46.66
  • 52 Week Low
  • EDSA $1.55
  • JTAI $3.29
  • 52 Week High
  • EDSA $5.99
  • JTAI $324.00
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 40.80
  • JTAI 40.40
  • Support Level
  • EDSA $1.56
  • JTAI $3.42
  • Resistance Level
  • EDSA $1.97
  • JTAI $4.05
  • Average True Range (ATR)
  • EDSA 0.15
  • JTAI 0.51
  • MACD
  • EDSA 0.02
  • JTAI 0.11
  • Stochastic Oscillator
  • EDSA 31.84
  • JTAI 15.33

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: